Skip to main content
Equibles

EVGN · Evogene Ltd. · Webcasts, Transcripts & Audio

Track EVGN — free

Use EVGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EVGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.37 +0.00 (+0.70%)
Rebalance outlook locked
Market Cap
$5.87M
Shares
15.80M
Volume · Oct 20 11.12K Avg daily vol (3M) 1.41M

Evogene Ltd. Webcasts

Earnings calls, investor updates, investor days and conferences for Evogene Ltd. (EVGN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Earnings call
FY26 · Q2
2026-08-18
Evogene Ltd. (EVGN) Q2 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-20
Evogene Ltd. (EVGN) Q1 2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Evogene Ltd. (EVGN) Q4 2025 Earnings Call Transcript
Confident tone Forward catalysts and pipeline ChemPass AI platform and differentiation Divestitures and financial position
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Evogene Ltd. (EVGN) Q3 2025 Earnings Call Transcript
Positive tone Divestitures and discontinued operations AgPlenus and agriculture activity Casterra castor seed business
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Date not confirmed
Evogene Ltd. (EVGN) Q2 2025 Earnings Call Transcript
Positive tone Casterra castor seed business Pharma collaborations Asset sales to ICL and cash position
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Evogene Ltd. (EVGN) Q1 2025 Earnings Call Transcript
Positive tone Lavie Bio sale to ICL Casterra seed sales and castor oil market Biomica clinical program
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-12-31
Date not confirmed
Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript
Positive tone Revenue growth and Casterra seed sales Subsidiary 2025 targets and milestones AgPlenus collaboration with Bayer
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Evogene Ltd. (EVGN) Q3 2024 Earnings Call Transcript
Positive tone AgPlenus Internal Pipeline Biomica BMC128 Clinical Progress Lavie Bio / Yalos Bio-inoculant Commercial Expansion
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-07-24
Evogene Ltd. (EVGN) Q2 2024 Earnings Call Transcript
Positive tone Production capacity and scaling AgPlenus herbicide pipeline and partnerships Biomica BMC128 clinical results
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-23
Evogene Ltd. (EVGN) Q1 2024 Earnings Call Transcript
Confident tone Subsidiary partnerships with major agritech companies Casterra castor seed supply and ENI orders CPB platform and AI tech-engines
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Evogene Ltd. (EVGN) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-15
Evogene Ltd. (EVGN) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–12 of 12 webcasts
Key facts CIK 1574565 CUSIP M4119S187 13F (30d) 1 filings 1 filers Visit website Investor relations